Advances in Preoperative Imaging-based Risk Stratification for Endometrial Carcinoma: A Comprehensive Review

Yanshan Ouyang; Yiying Cao; Yingning Wu

doi:10.54097/fqyw2t80

Authors

Yanshan Ouyang
Yiying Cao
Yingning Wu

DOI:

https://doi.org/10.54097/fqyw2t80

Keywords:

Endometrial Carcinoma, Risk Stratification, Imaging, Radiomics, Presurgical Evaluation

Abstract

Endometrial carcinoma (EC) risk stratification is important to guide individualized treatment and prognostic assessment. Accurate preoperative risk stratification can help optimize surgical plans and adjuvant treatment strategies. Conventional imaging plays an important role in risk assessment, including tumor size, myometrial infiltration depth, cervical stromal invasion, lymph node metastatic status, dynamic enhancement pattern, and signal characteristics of diffusion-weighted imaging. By extracting high-throughput features from medical images and combining them with artificial intelligence algorithms, radiomics is able to assess tumor heterogeneity in a more comprehensive way, providing a new method for noninvasive risk stratification. This article describes the research results of traditional imaging and imaging histology in EC risk stratification, discussing the technical advantages, challenges, and future development directions.

Downloads

Download data is not yet available.

References

[1] R-L Siegel, Giaquinto A-N, Jemal A. Cancer statistics, 2024[J]. CA Cancer J Clin, 2024, 74(1): 12-49.

[2] A Oaknin, Bosse T-J, Creutzberg C-L, et al. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up[J]. Ann Oncol, 2022, 33(9): 860-877.

[3] R-A Brooks, Fleming G-F, Lastra R-R, et al. Current recommendations and recent progress in endometrial cancer[J]. CA Cancer J Clin, 2019, 69(4): 258-279.

[4] N Concin, Matias-Guiu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma[J]. Int J Gynecol Cancer, 2021, 31(1): 12-39.

[5] K Gorzelnik, Szubert S, Knafel A, et al. An analysis of the significance of the lymph node ratio and extracapsular involvement in the prognosis of endometrial cancer patients[J]. Contemp Oncol (Pozn), 2022, 26(2): 144-149.

[6] R-W Green, Epstein E. Dynamic contrast-enhanced ultrasound improves diagnostic performance in endometrial cancer staging[J]. Ultrasound Obstet Gynecol, 2020, 56(1): 96-105.

[7] R-A Brooks, Fleming G-F, Lastra R-R, et al. Current recommendations and recent progress in endometrial cancer[J]. CA Cancer J Clin, 2019, 69(4): 258-279.

[8] Q Zhang, Yu X, Lin M, et al. Multi-b-value diffusion weighted imaging for preoperative evaluation of risk stratification in early-stage endometrial cancer[J]. Eur J Radiol, 2019, 119108637.

[9] C Huang, Luo Y,Yang C,et al.Study on the value of evaluating the risk stratification of early endometrial cancer based on preoperative DWI and semiquantitative dynamic contrast-enhanced MRI[J]. Journal of Medical Imaging, 2023, 33(11): 2038-204312.(in Chinese with English abstract)

[10] H Wang, Yan R, Li Z, et al. Quantitative dynamic contrast-enhanced parameters and intravoxel incoherent motion facilitate the prediction of TP53 status and risk stratification of early-stage endometrial carcinoma[J]. Radiol Oncol, 2023, 57(2): 257-269.

[11] M Atri, Zhang Z, Dehdashti F, et al. Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial[J]. Radiology, 2017, 283(2): 450-459.

[12] Y Yang, Pan Y-Q, Wang M, et al. Retrospective analysis of the (18)F-FDG PET/CT cutoff value for metabolic parameters was performed as a prediction model to evaluate risk factors for endometrial cancer[J]. Radiat Oncol, 2023, 18(1): 196.

[13] J-A Adam, Poel E, van Eck Smit-BLF, et al. [(18)F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer[J]. BMC Cancer, 2024, 24(1): 513.

[14] J-P Alderuccio, Reis I-M, Hamadani M, et al. PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial[J]. Clin Cancer Res, 2024, 30(1): 139-149.

[15] Y Nose, Makino T, Tatsumi M, et al. Risk stratification of oesophageal squamous cell carcinoma using change in total lesion glycolysis and number of PET-positive lymph nodes[J]. Br J Cancer, 2023, 128(10): 1879-1887.

[16] D-D Liu, Li J, Li X, et al. Prognostic value of metabolic tumor volume and total lesion glycolysis from (1)(8)F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma[J]. J Gynecol Oncol, 2019, 30(6): e89.

[17] Z Liu, Wang S, Dong D, et al. The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges[J]. Theranostics, 2019, 9(5): 1303-1322.

[18] P Shrestha, Poudyal B, Yadollahi S, et al. A systematic review on the use of artificial intelligence in gynecologic imaging - Background, state of the art, and future directions[J]. Gynecol Oncol, 2022, 166(3): 596-605.

[19] F Moro, Albanese M, Boldrini L, et al. Developing and validating ultrasound-based radiomics models for predicting high-risk endometrial cancer[J]. Ultrasound Obstet Gynecol, 2022, 60(2): 256-268.

[20] X Liu, Xiao W, Qiao J, et al. Prediction of Lymph Node Metastasis in Endometrial Cancer Based on Color Doppler Ultrasound Radiomics[J]. Acad Radiol, 2024, 31(11): 4499-4508.

[21] Q Li, Huang Y, Xia Y, et al. Radiogenomics for predicting microsatellite instability status and PD-L1 expression with machine learning in endometrial cancers: A multicenter study[J]. Heliyon, 2023, 9(12): e23166.

[22] X-L Song, Luo H-J, Ren J-L, et al. Multisequence magnetic resonance imaging-based radiomics models for the prediction of microsatellite instability in endometrial cancer[J]. Radiol Med, 2023, 128(2): 242-251.

[23] Z Lin, Wang T, Li Q, et al. Development and validation of MRI-based radiomics model to predict recurrence risk in patients with endometrial cancer: a multicenter study[J]. Eur Radiol, 2023, 33(8): 5814-5824.

[24] D Liu, Huang J, Zhang Y, et al. Multimodal MRI-based radiomics models for the preoperative prediction of lymphovascular space invasion of endometrial carcinoma[J]. BMC Med Imaging, 2024, 24(1): 252.

[25] M Virarkar, Daoud T, Sun J, et al. MRI Radiomics Data Analysis for Differentiation between Malignant Mixed Mullerian Tumors and Endometrial Carcinoma[J]. Cancers (Basel), 2024, 16(15).

[26] Y Lin, Wu R-C, Lin Y-C, et al. Endometrial cancer risk stratification using MRI radiomics: corroborating with choline metabolism[J]. Cancer Imaging, 2024, 24(1): 112.

[27] V Celli, Guerreri M, Pernazza A, et al. MRI- and Histologic-Molecular-Based Radio-Genomics Nomogram for Preoperative Assessment of Risk Classes in Endometrial Cancer [J]. Cancers (Basel), 2022, 14(23).

[28] T-L Lefebvre, Ueno Y, Dohan A, et al. Development and Validation of Multiparametric MRI-based Radiomics Models for Preoperative Risk Stratification of Endometrial Cancer[J]. Radiology, 2022, 305(2): 375-386.

[29] K Bera, Braman N, Gupta A, et al. Predicting cancer outcomes with radiomics and artificial intelligence in radiology[J]. Nat Rev Clin Oncol, 2022, 19(2): 132-146.

[30] B Gu, Meng M, Xu M, et al. Multi-task deep learning-based radiomic nomogram for prognostic prediction in locoregionally advanced nasopharyngeal carcinoma[J]. Eur J Nucl Med Mol Imaging, 2023, 50(13): 3996-4009.

[31] A-A Theodosiou, Read R-C. Artificial intelligence, machine learning and deep learning: Potential resources for the infection clinician[J]. J Infect, 2023, 87(4): 287-294.

[32] Y-X Li, Lu Y, Song Z-M, et al. Ultrasound-based machine learning model to predict the risk of endometrial cancer among postmenopausal women[J]. BMC Med Imaging, 2025, 25(1): 244.

[33] J Yang, Cao Y, Zhou F, et al. Combined deep-learning MRI-based radiomic models for preoperative risk classification of endometrial endometrioid adenocarcinoma[J]. Front Oncol, 2023, 131231497.